Home/Filings/4/0001062993-23-011547
4//SEC Filing

Celano Michael 4

Accession 0001062993-23-011547

CIK 0001374690other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 2:13 PM ET

Size

5.1 KB

Accession

0001062993-23-011547

Insider Transaction Report

Form 4
Period: 2023-05-17
Celano Michael
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2023-05-17$3.73/sh+5,000$18,632112,746 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.71 to $3.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Issuer

Larimar Therapeutics, Inc.

CIK 0001374690

Entity typeother

Related Parties

1
  • filerCIK 0001377582

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 2:13 PM ET
Size
5.1 KB